The Ensign Group, Inc. (NASDAQ:ENSG) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.
According to Zacks, “The Ensign Group operates in the booming post-acute care industry that holds untapped opportunities. In addition, the company’s consistently rising revenues on the back of robust inorganic growth is impressive. Its strong underwriting results have been mainly backed by its solid fundamentals. However, the company is exposed to headwinds like rising expenses, heavy debt burden and regulatory uncertainty created by the surprise victory of Donald Trump. Stringent regulations faced by the non-U.S operations of the company also raise concerns. Well reflective of these headwinds, the shares of Ensign Group has lost 14.6% year to date, much wider than the 2% loss incurred by the Zacks categorized Nursing Homes industry. Even the Zacks Consensus Earnings estimate has remained flat for 2017 and revised downward for 2018, over past sixty days.”
Several other equities research analysts have also commented on ENSG. Royal Bank of Canada reiterated a “buy” rating on shares of The Ensign Group in a research report on Friday, February 10th. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $26.00 price objective (down from $29.00) on shares of The Ensign Group in a research report on Friday, February 10th. Finally, Wells Fargo & Co lowered shares of The Ensign Group from a “market perform” rating to an “underperform” rating in a research report on Friday, April 28th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $22.60.
The Ensign Group (NASDAQ ENSG) traded down 0.47% during trading on Tuesday, hitting $18.88. 57,025 shares of the stock traded hands. The Ensign Group has a 52-week low of $16.50 and a 52-week high of $23.18. The company’s 50 day moving average price is $18.95 and its 200-day moving average price is $19.78. The stock has a market cap of $957.25 million, a P/E ratio of 22.77 and a beta of 0.95.
The Ensign Group (NASDAQ:ENSG) last released its quarterly earnings data on Monday, May 1st. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.33 by $0.01. The Ensign Group had a net margin of 3.02% and a return on equity of 13.94%. The business had revenue of $441.74 million for the quarter, compared to analyst estimates of $435.72 million. Equities research analysts forecast that The Ensign Group will post $1.49 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “The Ensign Group, Inc. (ENSG) Upgraded by Zacks Investment Research to “Hold”” was posted by Mideast Time and is the sole property of of Mideast Time. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.mideasttime.com/the-ensign-group-inc-ensg-upgraded-by-zacks-investment-research-to-hold-2/1756650.html.
In other news, Director John G. Nackel bought 3,462 shares of The Ensign Group stock in a transaction on Friday, April 28th. The shares were bought at an average cost of $17.55 per share, for a total transaction of $60,758.10. Following the acquisition, the director now owns 96,732 shares in the company, valued at $1,697,646.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Barry Port sold 3,884 shares of the company’s stock in a transaction dated Thursday, March 16th. The shares were sold at an average price of $18.13, for a total transaction of $70,416.92. Following the completion of the transaction, the vice president now owns 122,442 shares in the company, valued at $2,219,873.46. The disclosure for this sale can be found here. 6.50% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Bard Associates Inc. raised its position in The Ensign Group by 0.5% in the fourth quarter. Bard Associates Inc. now owns 134,620 shares of the company’s stock worth $2,990,000 after buying an additional 730 shares during the period. Two Sigma Investments LP purchased a new position in The Ensign Group during the fourth quarter worth about $1,059,000. Silvercrest Asset Management Group LLC purchased a new position in The Ensign Group during the fourth quarter worth about $277,000. A.R.T. Advisors LLC purchased a new position in The Ensign Group during the fourth quarter worth about $337,000. Finally, Skyline Asset Management LP raised its position in The Ensign Group by 10.3% in the fourth quarter. Skyline Asset Management LP now owns 937,200 shares of the company’s stock worth $20,815,000 after buying an additional 87,900 shares during the period. Institutional investors own 87.18% of the company’s stock.
The Ensign Group Company Profile
The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for The Ensign Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.